Breast Cancer
FDA news: Breast cancer, melanoma agents win fast track, orphan drug status
The FDA announced several regulatory actions the past few weeks.
FDA expands Trodelvy approval for breast cancer
The FDA expanded the approval of sacituzumab govitecan-hziy to include treatment of certain patients with hormone receptor-positive disease.
Sex and gender minority groups face disparities across breast cancer care continuum
Members of sex and gender minority groups experienced longer times from symptom onset to breast cancer diagnosis compared with a cohort of cisgender heterosexuals, according to study results published in JAMA Oncology.
Top in hem/onc: Smokers with breast cancer; hepatocellular carcinoma therapy
A recent study found that Black women who smoked at the time of breast cancer diagnosis had a greater risk for all-cause mortality than those who never smoked, highlighting the importance of smoking cessation.
Breast MRI superior to other supplemental methods for detecting cancer in dense breasts
Breast MRI was the most statistically effective supplemental screening tool for detecting cancer in dense breasts compared with other screening modalities, a study published in Radiology found.
Talazoparib may benefit patients with PALB2-mutated breast cancer
Talazoparib appeared effective among certain patients with advanced, PALB2-mutated breast cancer, according to study results published in Nature Cancer.
Age bias found in adjuvant therapy recommendations for women with early breast cancer
Women aged 69 years who underwent surgery for high-risk breast cancer received recommendations for adjuvant radiation therapy nearly two times more often than women a year older undergoing the same procedure, study results showed.
VIDEO: Studies ‘fine tuning’ use of trastuzumab deruxtecan in breast cancer
In this video, Paolo Tarantino, MD, discusses findings from DESTINY-Breast 04 presented at San Antonio Breast Cancer Symposium.
FDA approves elacestrant for advanced breast cancer
The FDA approved elacestrant for certain patients with advanced or metastatic breast cancer.
Molecular microscopy maps growth of breast cancer in new detail
New technology that identifies which populations of breast cancer cells are likely to drive invasion and metastasis has revealed that the location of cancer cells may be as essential to tumor growth as mutations.